The impact of lipophilicity as represented by the logarithm of octanol/water partition coefficient (logP), the combined steric/polarizability effect as represented by molar refractivity (MR) and bulk as represented by molar volume (MV) on the biological activity of 29 known aminopyrimidoisoquinolinequinones APIQ were analyzed using quantitative structure activity relationships methodology (QSAR). The activity data chosen was the inhibitory concentration (IC50) against human gastric adenocarcinoma (AGS) cell line. On running regression analysis, the physicochemical parameters and IC50 show very weak correlations as evident by the low values of Pearson Correlation R2 (0.1 to 0.2). Since the individual compounds show appreciable activity (ranging from 20 to 0.5 μM), classification was resorted to in order to expose mechanistic nesting subgroups. This was done by clustering data points around various trend lines extracted from the scattered plot relating parameters to activity using R2 as an index. The correlation of IC50 versus MV was chosen a base of classification owing to higher statistical metrics it yield. This gave five regression lines, each of which is believed to represent a separate mechanistic profile. Additional descriptors were used to consolidate the clustering approach and to give depth to the assumed mechanistic profiles of each cluster.
References
[1]
Tambama, P., Abegaz, B. and Mukanganyama, S. (2014) Antiproliferative Activity of the Isofuranonaphthoquinone Isolated from Bulbine Frutescens against Jurkat T Cell. BioMed Research International, 2014, Article ID: 752941. https://doi.org/10.1155/2014/752941
[2]
Wakharde, A.A., Awad, A.H., Bhagat, A. and Karuppayil, S.M. (2018) Synergistic Activation of Doxorubicin against Cancer: A Review. American Journal of Clinical Microbiology and Antimicrobials, 1, 1-6. http://www.remedypublications.com
[3]
Patrick, G.L. (2013) An Introduction to Medicinal Chemistry. 5th Edition, Oxford University Press, Oxford, 524.
[4]
Sauter, K.A.D., Wood, L.J., Wong, J., Iordanov, M. and Magun, B.E. (2011) Doxorubicin and Daunorubicin Induce Processing and Release of Interleukin-1β through Activation of the NLRP3 Inflammasome. Cancer Biology & Therapy, 11, 1008-1016. https://doi.org/10.4161/cbt.11.12.15540
[5]
Minotti, G., Menna, P., Salvatorelli, E., Cairo, G. and Gianni, L. (2004) Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity. Pharmacological Reviews, 56, 185. https://doi.org/10.1124/pr.56.2.6
[6]
Cai, F.F., et al. (2019) Anthracycline-Induced Cardiotoxicity in the Chemotherapy Treatment of Breast Cancer: Preventive Strategies and Treatment (Review). Molecular and Clinical Oncology, 11, 15.
[7]
Xu, X., Persson, H.L. and Richardson, D.R. (2005) Molecular Pharmacology of the Interaction of Anthracyclines with Iron. Molecular Pharmacology, 68, 261. https://doi.org/10.1124/mol.105.013383
[8]
Albini, A., Pennesi, G., Donatelli, F., Cammarota, R., De Flora, S. and Noonan, D.M. (2010) Cardiotoxicity of Anticancer Drugs: The Need for Cardio-Oncology and Cardio-Oncological Prevention. Journal of the National Cancer Institute, 102, 14. https://doi.org/10.1093/jnci/djp440
Avendaño, C. and Menéndez, J.C. (2015) Medicinal Chemistry of Anticancer Drugs. 2nd Edition, Elsevier, Amsterdam, 305.
[11]
Reis-Mendes, A., Alves, M., Valho, F.C., Remião, F., Bastos, M.L. and Costa, V.M. (2018) Pixantrone, a New Anticancer Drug with the Same Old Cardiac Problems? An in Vitro Study with Differentiated and Non-Differentiated H9c2 Cells. Interdisciplinary Toxicology, 11, 13. https://doi.org/10.2478/intox-2018-0002
[12]
Rahman, A.M., Yusuf, S.W. and Ewer, M.S. (2007) Anthracycline-Induced Cardiotoxicity and the Cardiac-Sparing Effect of Liposomal Formulation. International Journal of Nanomedicine, 2, 567. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2676818
[13]
Sissi, C., Moro, S., Richter, S., Gatto, B., Menta, E., Spinelli, S., Krapcho, A.P., Zunino, F. and Palumbo, M. (2000) DNA-Interactive Anticancer Aza-Anthrapyrazoles: Biophysical and Biochemical Studies Relevant to the Mechanism of Action. Molecular Pharmacology, 59, 96. https://doi.org/10.1124/mol.59.1.96
[14]
Kumar, H., Saini, D., Jain, S. and Jain, N. (2013) Pyrazole Scaffold: A Remarkable Tool in the Development of Anticancer Agents. European Journal of Medicinal Chemistry, 70, 248. https://doi.org/10.1016/j.ejmech.2013.10.004
[15]
Ma, M., Rateb, M.E., Teng, Q.H., Yang, D., Rudolf, J.D., Zhu, X.C., Huang, Y., Zhao, L.-X., Jiang, Y., Li, X.L., Rader, C., Duan, Y.W. and Shen, B. (2015) Angucyclines and Angucyclinones from Streptomyces sp. CB01913 Featuring C-Ring Cleavage and Expansion. Journal of Natural Products, 78, 2471. https://doi.org/10.1021/acs.jnatprod.5b00601
[16]
Xie, Z.P., Liu, B., Wang, H.P., Yang, S.X., Zhang, H.Y., Wang, Y.P., Ji, N.Y., Qin, S. and Laatsch, H. (2012) Kiamycin, a Unique Cytotoxic Angucyclinone Derivative from a Marine Streptomyces sp. Mar. Drugs, 10, 551. https://doi.org/10.3390/md10030551
[17]
Cuellar, M., Quiñones, N., Villena, J. and Salas, C. (2013) Synthesis and Citotoxicity Activity of New Aza-Analogues of Angucyclinones from (−)-Shikimic Acid. 15th BMOS, Vol. 1, 10. https://doi.org/10.5151/chempro-15bmos-BMOS2013_201382005353
[18]
Quiñones, N., Hernández, S., Catalán, L.E., Villena, J., Brito, I., Cabrera, A.R., Salas, C.O. and Cuellar, M.A. (2018) (−)-Shikimic Acid as a Chiral Building Block for the Synthesis of New Cytotoxic 6-Aza-Analogues of Angucyclinones. Molecules, 23, 1422. https://doi.org/10.3390/molecules23061422
[19]
Vásquez, D., Rodríguez, J.A., Theoduloz, C., Verrax, J., Calderon, P.B. and Valderrama, J.A. (2009) Synthesis and Antitumor Evaluation of 8-Phenylaminopyrimido [4,5-c]isoquinolinequinones. Bioorganic & Medicinal Chemistry Letters, 19, 5060. https://doi.org/10.1016/j.bmcl.2009.07.041
[20]
Vásquez, D., Rodriguez, J.A., Theoduloz, C., Calderon, P.B. and Valderrama, J.A. (2010) Studies on Quinones. Part 46. Synthesis and in Vitro Anti-Tumour Evaluation of Aminopyrimidoisoquinolinequinones. European Journal of Medicinal Chemistry, 45, 5234. https://doi.org/10.1016/j.ejmech.2010.08.040
[21]
Valderrama, J.A., Ibacache, A., Rodriguez, J.A., Theoduloz, C. and Benites, J. (2011) Studies on Quinones. Part 47. Synthesis of Novel Phenylaminophenanthridinequinones as Potential Anti-Tumour Agents. European Journal of Medicinal Chemistry, 46, 3398. https://doi.org/10.1016/j.ejmech.2011.05.003
[22]
Pathan, S., Ali, S.M. and Shrivastava, M. (2016) Quantitative Structure Activity Relationship and Drug Design: A Review. International Journal of Research in BioSciences, 5, 1. http://www.ijrbs.in
[23]
Lo, Y.-C., Rensi, S.E., Torng, W. and Altman, R.B. (2018) Machine Learning in Chemoinformatics and Drug Discovery. Drug Discovery Today, 23, 1538. https://doi.org/10.1016/j.drudis.2018.05.010
[24]
Gramatica, P. (2013) On the Development and Validation of QSAR Models. Methods in Molecular Biology, 930, 499. https://doi.org/10.1007/978-1-62703-059-5_21
[25]
Roy, K., Das, S., et al. (2015) A Primer on QSAR/QSPR Modeling. Springer, Berlin. http://www.springer.com https://doi.org/10.1007/978-3-319-17281-1
[26]
Parmar, M. (2018) Comparative Analysis of Classification Techniques Using WEKA on Different Datasets. International Journal of Latest Engineering and Management Research, 3, 1. http://www.researchgate.net/publication/325872035
[27]
Hashim, H.A., El-Fakii, M.O. and Saeed, A.E.M. (2015) Anticancer Activity Trends of 5-Substituted 2 (2-Diethylamino)ethyl Anthrapyrazoles toward L1210 Murine Leukemia: A QSAR Analysis. Lebda Medical Journal, 1, 20. http://www.elmergib.edu.ly/euj/index.php/LMJ/index
[28]
Sarwar, M.W., Riaz, A., Dilshad, S.M.R., Al-Qahtani, A., Nawaz-Ul-Rehman, M.S. and Mubin, M. (2018) SAR and QSAR Studies Showed Plant Flavonoids as Potential Inhibitors of Dengue NS2B-NS3 Protease. BMC Structural Biology, 18, 6. https://doi.org/10.1186/s12900-018-0084-5
[29]
Todeschini, R. and Consonni, V. (2009) Molecular Descriptors for Chemoinformatics. 2nd Edition, Vol. 1, Wiley-VCH, Weinheim, 247, 362, 388, 629.
